Carrier Free, ExactAb™, Low Endotoxin, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA Animal Free,Carrier Free,ExactAb™,Low Endotoxin,Validated for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -80°C,Avoid repeated freezing and thawing Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Romlusevimab (anti-Spike RBD) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Romlusevimab (anti-Spike RBD) (Ab209843) - ELISA
Immobilized Recombinant Human Spike RBD (rp155929) protein at 1.0 μg/mL can bind Romlusevimab (anti-Spike RBD) (Ab209843) with the EC50 of 48.61 ng/mL.
Romlusevimab (anti-Spike RBD) (Ab209843) - SEC
The purity of Romlusevimab (anti-Spike RBD) (Ab209843) is more than 95% verified by HPLC.
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ25F0217708 | Certificate of Analysis | Feb 11, 2025 | Ab209843 |
| ZJ25F0217707 | Certificate of Analysis | Feb 11, 2025 | Ab209843 |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Animal Free grade guide → View Carrier Free grade guide → View Validated grade guide → View ExactAb™ grade guide → View Low Endotoxin grade guide →
